loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 208025 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 DEXCEL (1)

filter

01 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL (1)

filter

01 OTC (1)

filter

01 LANSOPRAZOLE (1)

filter

01 No (1)

URL Supplier Web Content
TABLET, ORALLY DIS...
15MG
2016-06-07
208025
LANSOPRAZOLE
OTC
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 208025

Looking for FDA Orange Book APPLICATION 208025 1

19

Dexcel Pharma, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LANSOPRAZOLE, with a corresponding application number 208025.

Regulatory Information OTC

With a dosage strength 15MG

Dosage Form Route TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; ORAL

Reference Listed Drug No

Approved since 2016-06-07

Post Enquiry
POST ENQUIRY